Insulin Dose and Cardiovascular Mortality in the ACCORD Trial
- Siraj, Elias S.
- Rubin, Daniel J.
- Riddle, Matthew C.
- Miller, Michael E.
- Hsu, Fang-Chi
- Ismail-Beigi, Faramarz
- Chen, Shyh-Huei
- Ambrosius, Walter T.
- Thomas, Abraham
- Bestermann, William
- Buse, John B.
- Genuth, Saul
- Joyce, Carol
- Kovacs, Christopher S.
- O'Connor, Patrick J.
- Sigal, Ronald J.
- Solomon, Sol
Publication date
January 2015
DOIAbstract
In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (CV) risk was associated with higher all-cause and CV mortality. Post hoc analyses have failed to implicate rapid reduction of glucose, hypoglycemia, or specific drugs as the causes of this finding. We hypothesized that exposure to injected insulin was quantitatively associated with increased CV mortality
Add to ORKG